Skip to main content
Log in

Percutaneous Microwave Ablation of Renal Angiomyolipomas

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the safety and efficacy of US-guided percutaneous microwave (MW) ablation in the treatment of renal angiomyolipoma (AML).

Materials and Methods

From January 2011 to April 2014, seven patients (5 females and 2 males; mean age 51.4) with 11 renal AMLs (9 sporadic type and 2 tuberous sclerosis associated) with a mean size of 3.4 ± 0.7 cm (range 2.4–4.9 cm) were treated with high-powered, gas-cooled percutaneous MW ablation under US guidance. Tumoral diameter, volume, and CT/MR enhancement were measured on pre-treatment, immediate post-ablation, and delayed post-ablation imaging. Clinical symptoms and creatinine were assessed on follow-up visits.

Results

All ablations were technically successful and no major complications were encountered. Mean ablation parameters were ablation power of 65 W (range 60–70 W), using 456 mL of hydrodissection fluid per patient, over 4.7 min (range 3–8 min). Immediate post-ablation imaging demonstrated mean tumor diameter and volume decreases of 1.8 % (3.4–3.3 cm) and 1.7 % (27.5–26.3 cm3), respectively. Delayed imaging follow-up obtained at a mean interval of 23.1 months (median 17.6; range 9–47) demonstrated mean tumor diameter and volume decreases of 29 % (3.4–2.4 cm) and 47 % (27.5–12.1 cm3), respectively. Tumoral enhancement decreased on immediate post-procedure and delayed imaging by CT/MR parameters, indicating decreased tumor vascularity. No patients required additional intervention and no patients experienced spontaneous bleeding post-ablation.

Conclusion

Our early experience with high-powered, gas-cooled percutaneous MW ablation demonstrates it to be a safe and effective modality to devascularize and decrease the size of renal AMLs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168:1315–25.

    Article  PubMed  Google Scholar 

  2. Seyam RM, Bissada NK, Kattan SA, et al. Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology. 2008;72:1077–82.

    Article  PubMed  Google Scholar 

  3. Oesterling JE, Fishman EK, Goldman SM, et al. The management of renal angiomyolipoma. J Urol. 1986;135:1121–4.

    CAS  PubMed  Google Scholar 

  4. Sivalingam S, Nakada SY. Contemporary minimally invasive treatment options for renal angiomyolipomas. Curr Urol Rep. 2013;14:147–53.

    Article  PubMed  Google Scholar 

  5. Kothary N, Soulen MC, Clark TW, et al. Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol. 2005;16:45–50.

    Article  PubMed  Google Scholar 

  6. Ramon J, Rimon U, Garniek A, Golan G, Bensaid P, Kitrey ND, Nadu A, Dotan ZA. Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol. 2009;55(5):1155–61. doi:10.1016/j.eururo.2008.04.025.

    Article  PubMed  Google Scholar 

  7. Laeseke PF, Lee FT Jr, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol. 2009;20:1224–9.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Pop M, Davidson SRH, Gertner M, Jewett MAS, Sherar MD, Kolios MC. A theoretical model for RF ablation of kidney tissue and its experimental validation. ISMBS, vol. 5958., Lecture Notes in Computer ScienceBerlin: Springer; 2010. p. 119–29.

    Google Scholar 

  9. Solazzo SA, Liu Z, Lobo SM, Ahmed M, Hines-Peralta AU, Lenkinski RE, et al. Radiofrequency ablation: importance of background tissue electrical conductivity—an agar phantom and computer modeling study. Radiology. 2005;236(2):495–502.

    Article  PubMed  Google Scholar 

  10. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262(2):520–9. doi:10.1148/radiol.11101742.

    Article  PubMed  Google Scholar 

  11. Bishay VL, Crino PB, Wein AJ, Malkowicz SB, Trerotola SO, Soulen MC, Stavropoulos SW. Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol. 2010;21(1):67–72.

    Article  PubMed  Google Scholar 

  12. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;13:1271–9.

    Article  Google Scholar 

  13. Johnson SC, Graham S, D’Agostino H, Elmajian DA, Shingleton WB. Percutaneous renal cryoablation of angiomyolipomas in patients with solitary kidneys. Urology. 2009;74(6):1246–9. doi:10.1016/j.urology.2008.09.005.

    Article  PubMed  Google Scholar 

  14. Gregory SM, Anderson CJ, Patel U. Radiofrequency Ablation of Large Renal Angiomyolipoma: median-term follow-up. Cardiovasc Interv Radiol. 2013;36(3):682–9.

    Article  CAS  Google Scholar 

  15. Castle SM, Gorbatiy V, Ekwenna O, et al. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephronsparing surgery. BJU Int. 2012;109:384–7.

    Article  PubMed  Google Scholar 

  16. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127(2):208–23.

    Article  PubMed  Google Scholar 

  17. Zhou W, Liang M, Pan H, Liu X, Jiang Y, Wang Y, et al. Comparison of ablation zones among different tissues using 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine models. PLoS One. 2013;8(8):e71873.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Brace CL, Laeseke PF, Prasad V, Lee FT. Electrical isolation during radiofrequency ablation: 5% dextrose in water provides better protection than saline. Conf Proc IEEE Eng Med Biol Soc. 2006;1:5021–4.

    PubMed  Google Scholar 

  19. Guan W, Bai J, Liu J, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012;106:316–21.

    Article  PubMed  Google Scholar 

  20. Zhi-Yu H, Ping L, Xiao-Ling Y, Zhi-Gang C, Fang-Yi L, Jie Y. Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: preliminary results. Acta Radiol. 2014;56:56–62.

    Article  Google Scholar 

  21. Tan YK, Best SL, Olweny E, Park S, Trimmer C, Cadeddu JA. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol. Urology. 2012;79(4):827–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fred T. Lee Jr..

Ethics declarations

Conflict of Interest

Megan G. Lubner MD is a GE AUR Radiology Research Fellowship 2011–2013 grant recipient. J. Louis Hinshaw MD is a shareholder of Cellectar Biosciences, as well as a stockholder and former Board of Medical Advisors member for Neuwave Medical. Christopher L. Brace Ph.D. is a National Institutes of Health grant recipient for work with microwave ablation technology. He is a shareholder of, and receives personal fees from, NeuWave Medical, and has multiple patents related to thermal ablation, pending and issued. Fred T. Lee Jr. MD is a shareholder and serves on the board of directors of NeuWave Medical. He has multiple patents related to thermal ablation and receives inventor royalties from Covidien AG. Mircea Cristescu, E. Jason Abel MD, Shane Wells MD, Timothy J. Ziemlewicz MD, Sean P. Hedican MD have nothing to disclose.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Does not apply.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cristescu, M., Abel, E.J., Wells, S. et al. Percutaneous Microwave Ablation of Renal Angiomyolipomas. Cardiovasc Intervent Radiol 39, 433–440 (2016). https://doi.org/10.1007/s00270-015-1201-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-015-1201-5

Keywords

Navigation